Nagai H, Kim YH. Cancer prevention from the perspective of global cancer burden patterns. J Thorac Dis. 2017;9(3):448–51.

Article  PubMed  PubMed Central  Google Scholar 

Khorana AA, Dalal M, Lin J, Connolly GC. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States. Cancer. 2013;119(3):648–55.

Article  CAS  PubMed  Google Scholar 

Blann AD, Dunmore S. Arterial and venous thrombosis in cancer patients. Cardiol Res Pract. 2011;2011:394740.

Article  PubMed  PubMed Central  Google Scholar 

Abdulla A, Davis WM, Ratnaweera N, Szefer E, Ballantyne Scott B, Lee AYY. A Meta-Analysis of Case Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding in Patients with Cancer. Thromb Haemost. 2020;120(4):702–13.

Article  PubMed  Google Scholar 

Stein PD, Beemath A, Meyers FA, Skaf E, Sanchez J, Olson RE. Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med. 2006;119(1):60–8.

Article  PubMed  Google Scholar 

Lyman GH, Culakova E, Poniewierski MS, Kuderer NM. Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer. Thromb Res. 2018;164(Suppl 1):S112–8.

Article  CAS  PubMed  Google Scholar 

Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost. 2007;5(3):632–4.

Article  CAS  PubMed  Google Scholar 

Elyamany G, Alzahrani AM, Bukhary E. Cancer-associated thrombosis: an overview. Clin Med Insights Oncol. 2014;8:129–37.

Article  PubMed  PubMed Central  Google Scholar 

Mulder FI, Horváth-Puhó E, van Es N, van Laarhoven HWM, Pedersen L, Moik F, et al. Venous thromboembolism in cancer patients: a population-based cohort study. Blood. 2021;137(14):1959–69.

Article  CAS  PubMed  Google Scholar 

Heit JAOFW, Petterson TM, Lohse CM, Silverstein MD, Mohr DN, Melton LJ 3rd. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: A population-based study. Arch Intern Med. 2002;162:1245–8.

Article  PubMed  Google Scholar 

Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005;293(6):715–22.

Article  CAS  PubMed  Google Scholar 

Prandoni P, Lensing AW, Piccioli A, Bernardi E, Simioni P, Girolami B, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood. 2002;100(10):3484–8.

Article  CAS  PubMed  Google Scholar 

Weitz JI, Haas S, Ageno W, Goldhaber SZ, Turpie AGG, Goto S, et al. Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE. J Thromb Thrombolysis. 2020;50(2):267–77.

Article  CAS  PubMed  Google Scholar 

Navi BB, Reiner AS, Kamel H, Iadecola C, Okin PM, Elkind MSV, et al. Risk of Arterial Thromboembolism in Patients With Cancer. J Am Coll Cardiol. 2017;70(8):926–38.

Article  PubMed  PubMed Central  Google Scholar 

Yu J, Li A, Laureano M, Crowther M. Frequency of arterial thromboembolism in populations with malignancies: A systematic review. Thromb Res. 2019;184:16–23.

Article  CAS  PubMed  Google Scholar 

Varki A. Trousseau’s syndrome: multiple definitions and multiple mechanisms. Blood. 2007;110(6):1723–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

R. V. Weitere Unter-suchungen huber die Verstopgung der Lungenarterie und ihre Folgen. In: Virchow R, ed. Gesammelte Abhandlungen zur wissenschaftlichen Medizin. Meidinger Sohn: Frankfurt am Main. 1856;227–380.

Portillo J, de la Rocha IV, Font L, Braester A, Madridano O, Peromingo JA, et al. Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE registry. Thromb Res. 2015;136(6):1199–203.

Article  CAS  PubMed  Google Scholar 

Campia U. Vascular effects of cancer treatments. Vasc Med (London, England). 2020;25(3):226–34.

Article  CAS  Google Scholar 

Falanga A, Rickles FR. The pathogenesis of thrombosis in cancer. New Oncol Thrombosis. 2005;1:9–16.

Google Scholar 

Mukai M, Oka T. Mechanism and management of cancer-associated thrombosis. J Cardiol. 2018;72(2):89–93.

Article  PubMed  Google Scholar 

Falanga A, Marchetti M. Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity. J Thromb Haemost. 2023;21(6):1397–408.

Article  PubMed  Google Scholar 

Nachman RL, Silverstein R. Hypercoagulable states. Ann Intern Med. 1993;119(8):819–27.

Article  CAS  PubMed  Google Scholar 

Prosciak MP SS. Hypercoagulable states: A concise review. Int J Acad Med 2017;3:Suppl S1:82–95. https://doi.org/10.4103/IJAM.IJAM_18_17.

Boccaccio C, Sabatino G, Medico E, Girolami F, Follenzi A, Reato G, et al. The MET oncogene drives a genetic programme linking cancer to haemostasis. Nature. 2005;434(7031):396–400.

Article  CAS  PubMed  Google Scholar 

Yu JL, May L, Lhotak V, Shahrzad S, Shirasawa S, Weitz JI, et al. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood. 2005;105(4):1734–41.

Article  CAS  PubMed  Google Scholar 

Hisada Y, Mackman N. Tissue factor and cancer: regulation, tumor growth, and metastasis. Semin Thromb Hemost. 2019;45(4):385–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khorana AA. Cancer and coagulation. Am J Hematol. 2012;87(Suppl 1):S82–7.

CAS  PubMed  PubMed Central  Google Scholar 

Diane Mege LP-D, Dubois C. Mechanisms of cancer-associated thrombosis. HemaSphere. 2019;3(S2):19–21.

Article  PubMed  PubMed Central  Google Scholar 

Date K, Ettelaie C, Maraveyas A. Tissue factor-bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancer. J Thromb Haemost. 2017;15(12):2289–99.

Article  CAS  PubMed  Google Scholar 

Nieuwland R, Gardiner C, Dignat-George F, Mullier F, Mackman N, Woodhams B, et al. Toward standardization of assays measuring extracellular vesicle-associated tissue factor activity. J Thromb Haemost. 2019;17(8):1261–4.

Article  PubMed  PubMed Central  Google Scholar 

Thomas GM, Panicot-Dubois L, Lacroix R, Dignat-George F, Lombardo D, Dubois C. Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo. J Exp Med. 2009;206(9):1913–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Geddings JE, Hisada Y, Boulaftali Y, Getz TM, Whelihan M, Fuentes R, et al. Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice. J Thromb Haemost. 2016;14(1):153–66.

Article  CAS  PubMed  Google Scholar 

Rousseau A, Van Dreden P, Khaterchi A, Larsen AK, Elalamy I, Gerotziafas GT. Procoagulant microparticles derived from cancer cells have determinant role in the hypercoagulable state associated with cancer. Int J Oncol. 2017;51(6):1793–800.